These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 23491717)

  • 1. Modulation of angiogenic factor VEGF by DNA-hsp65 vaccination in a murine CNS tuberculosis model.
    Zucchi FC; Tsanaclis AM; Moura-Dias Q; Silva CL; Pelegrini-da-Silva A; Neder L; Takayanagui OM
    Tuberculosis (Edinb); 2013 May; 93(3):373-80. PubMed ID: 23491717
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic efficacy of a tuberculosis DNA vaccine encoding heat shock protein 65 of Mycobacterium tuberculosis and the human interleukin 2 fusion gene.
    Changhong S; Hai Z; Limei W; Jiaze A; Li X; Tingfen Z; Zhikai X; Yong Z
    Tuberculosis (Edinb); 2009 Jan; 89(1):54-61. PubMed ID: 19056317
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The safety of post-exposure vaccination of mice infected with Mycobacterium tuberculosis.
    Derrick SC; Perera LP; Dheenadhayalan V; Yang A; Kolibab K; Morris SL
    Vaccine; 2008 Nov; 26(48):6092-8. PubMed ID: 18809446
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The contribution of a murine CNS-TB model for the understanding of the host-pathogen interactions in the formation of granulomas.
    Zucchi FC; Pelegrini-da-Silva A; Neder L; Silva CL; Tsanaclis AM; Takayanagui OM
    J Neurosci Methods; 2012 Apr; 206(1):88-93. PubMed ID: 22387263
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA vaccine using hemagglutinating virus of Japan-liposome encapsulating combination encoding mycobacterial heat shock protein 65 and interleukin-12 confers protection against Mycobacterium tuberculosis by T cell activation.
    Yoshida S; Tanaka T; Kita Y; Kuwayama S; Kanamaru N; Muraki Y; Hashimoto S; Inoue Y; Sakatani M; Kobayashi E; Kaneda Y; Okada M
    Vaccine; 2006 Feb; 24(8):1191-204. PubMed ID: 16216394
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel therapeutic vaccines [(HSP65 + IL-12)DNA-, granulysin- and Ksp37-vaccine] against tuberculosis and synergistic effects in the combination with chemotherapy.
    Kita Y; Hashimoto S; Nakajima T; Nakatani H; Nishimatsu S; Nishida Y; Kanamaru N; Kaneda Y; Takamori Y; McMurray D; Tan EV; Cang ML; Saunderson P; Dela Cruz EC; Okada M
    Hum Vaccin Immunother; 2013 Mar; 9(3):526-33. PubMed ID: 23249609
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunogenicity and protective efficacy of a DNA vaccine encoding the fusion protein of mycobacterium heat shock protein 65 (Hsp65) with human interleukin-2 against Mycobacterium tuberculosis in BALB/c mice.
    Wang LM; Bai YL; Shi CH; Gao H; Xue Y; Jiang H; Xu ZK
    APMIS; 2008 Dec; 116(12):1071-81. PubMed ID: 19133010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The study of novel DNA vaccines against tuberculosis: induction of pathogen-specific CTL in the mouse and monkey models of tuberculosis.
    Okada M; Kita Y; Nakajima T; Hashimoto S; Nakatani H; Nishimatsu S; Nishida Y; Kanamaru N; Kaneda Y; Takamori Y; McMurray D; Tan EV; Cang ML; Saunderson P; Dela Cruz EC
    Hum Vaccin Immunother; 2013 Mar; 9(3):515-25. PubMed ID: 23249543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel therapeutic vaccine: granulysin and new DNA vaccine against Tuberculosis.
    Okada M; Kita Y; Nakajima T; Kanamaru N; Hashimoto S; Nagasawa T; Kaneda Y; Yoshida S; Nishida Y; Nakatani H; Takao K; Kishigami C; Nishimatsu S; Sekine Y; Inoue Y; Matsumoto M; McMurray DN; De la Cruz EC; Tan EV; Abalos RM; Burgos JA; Saunderson P; Sakatani M
    Hum Vaccin; 2011; 7 Suppl():60-7. PubMed ID: 21546794
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of therapeutic and prophylactic vaccine against Tuberculosis using monkey and transgenic mice models.
    Kita Y; Okada M; Nakajima T; Kanamaru N; Hashimoto S; Nagasawa T; Kaneda Y; Yoshida S; Nishida Y; Nakatani H; Takao K; Kishigami C; Nishimatsu S; Sekine Y; Takamori Y; McMurray DN; De la Cruz EC; Tan EV; Abalos RM; Burgos JA; Saunderson P; Sakatani M
    Hum Vaccin; 2011; 7 Suppl():108-14. PubMed ID: 21263229
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A heterologous DNA priming-Mycobacterium bovis BCG boosting immunization strategy using mycobacterial Hsp70, Hsp65, and Apa antigens improves protection against tuberculosis in mice.
    Ferraz JC; Stavropoulos E; Yang M; Coade S; Espitia C; Lowrie DB; Colston MJ; Tascon RE
    Infect Immun; 2004 Dec; 72(12):6945-50. PubMed ID: 15557616
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel DNA vaccine containing multiple TB-specific epitopes cast in a natural structure elicits enhanced Th1 immunity compared with BCG.
    Gao H; Li K; Yu S; Xiong S
    Microbiol Immunol; 2009 Oct; 53(10):541-9. PubMed ID: 19780967
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incorporation of immunostimulatory motifs in the transcribed region of a plasmid DNA vaccine enhances Th1 immune responses and therapeutic effect against Mycobacterium tuberculosis in mice.
    Wu J; Ma H; Qu Q; Zhou WJ; Luo YP; Thangaraj H; Lowrie DB; Fan XY
    Vaccine; 2011 Oct; 29(44):7624-30. PubMed ID: 21856352
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Novel vaccines against M. tuberculosis].
    Okada M
    Kekkaku; 2006 Dec; 81(12):745-51. PubMed ID: 17240920
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel prophylactic and therapeutic vaccine against tuberculosis.
    Okada M; Kita Y; Nakajima T; Kanamaru N; Hashimoto S; Nagasawa T; Kaneda Y; Yoshida S; Nishida Y; Nakatani H; Takao K; Kishigami C; Inoue Y; Matsumoto M; McMurray DN; Dela Cruz EC; Tan EV; Abalos RM; Burgos JA; Saunderson P; Sakatani M
    Vaccine; 2009 May; 27(25-26):3267-70. PubMed ID: 19200841
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune modulation induced by tuberculosis DNA vaccine protects non-obese diabetic mice from diabetes progression.
    Santos Júnior RR; Sartori A; Bonato VL; Coelho Castelo AA; Vilella CA; Zollner RL; Silva CL
    Clin Exp Immunol; 2007 Sep; 149(3):570-8. PubMed ID: 17590177
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunogenicity and protective efficacy of a tuberculosis DNA vaccine expressing a fusion protein of Ag85B-Esat6-HspX in mice.
    Yuan W; Dong N; Zhang L; Liu J; Lin S; Xiang Z; Qiao H; Tong W; Qin C
    Vaccine; 2012 Mar; 30(14):2490-7. PubMed ID: 21704108
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vaccination of mice and cattle with plasmid DNA encoding the Mycobacterium bovis antigen MPB83.
    Chambers MA; Vordermeier H; Whelan A; Commander N; Tascon R; Lowrie D; Hewinson RG
    Clin Infect Dis; 2000 Jun; 30 Suppl 3():S283-7. PubMed ID: 10875801
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the Mtb72F polyprotein vaccine in a rabbit model of tuberculous meningitis.
    Tsenova L; Harbacheuski R; Moreira AL; Ellison E; Dalemans W; Alderson MR; Mathema B; Reed SG; Skeiky YA; Kaplan G
    Infect Immun; 2006 Apr; 74(4):2392-401. PubMed ID: 16552069
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The order of prime-boost vaccination of neonatal calves with Mycobacterium bovis BCG and a DNA vaccine encoding mycobacterial proteins Hsp65, Hsp70, and Apa is not critical for enhancing protection against bovine tuberculosis.
    Skinner MA; Wedlock DN; de Lisle GW; Cooke MM; Tascon RE; Ferraz JC; Lowrie DB; Vordermeier HM; Hewinson RG; Buddle BM
    Infect Immun; 2005 Jul; 73(7):4441-4. PubMed ID: 15972546
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.